MindMuscle was founded on the belief that neurofeedback technology should be held to the same standards as other clinical interventions: rigorous validation, transparent reporting, and ongoing accountability to patient outcomes.
We recognize that neurofeedback research has historically suffered from small sample sizes, inconsistent protocols, and publication bias. We are committed to advancing the field through structured clinical trials, open-source methodology, and collaboration with academic institutions.
Our team includes practicing clinicians who understand the realities of pediatric therapy environments. We design our technology to integrate seamlessly into existing workflows, support clinical decision-making, and provide meaningful data without creating additional burden.
Above all, we remain humble about what we know and transparent about what remains uncertain. Children with ADHD and autism deserve interventions backed by evidence, delivered by skilled clinicians, and continuously refined based on real-world outcomes.